Wealth Enhancement Trust Services’s Emergent Biosolutions EBS Stock Holding History

Wealth Enhancement Trust Services’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.22K	Buy	+145	New	+$1.21K	﹤0.01%	1080

Other funds holding EBS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return

Wealth Enhancement Trust Services's EBS Position: Q2 2026 in Review

Wealth Enhancement Trust Services opened a new position in Emergent Biosolutions (EBS) in Q2 2026: 145 shares worth $1.22K. The stake represents ﹤0.01% of the portfolio and ranks #1080 among its holdings.

120 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

Wealth Enhancement Trust Services held 145 shares of Emergent Biosolutions worth $1.22K as of Q2 2026.
Emergent Biosolutions was a new Wealth Enhancement Trust Services position in Q2 2026.
Emergent Biosolutions made up ﹤0.01% of Wealth Enhancement Trust Services's portfolio in Q2 2026, its #1080 holding.
120 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q2 2026, filed 15 Jul 2026.